Dr Priya Sammani ( MBBS ,DFM )You know, it’s often during a routine check-up, one of those "just making sure everything's okay" visits, that we stumble upon things. You feel fine, maybe a little tired, but who isn’t these days? #cardiovasculardisease #hightriglycerides #hypertriglyceridemia #lifestylechanges #lipidpanel #pancreatitis #triglycerides
I remember a patient, let’s call him Mark. He breezed in for his annual check-up, feeling absolutely fine, full of energy. Then his blood test results came back. The number that really stood out? #atherosclerosis #cardiovasculardisease #hearthealth #hightriglycerides #hypertriglyceridemia #lowertriglycerides #triglycerides
I remember a patient, let's call him Mark. He breezed in for his annual check-up, feeling absolutely fine, full of energy. Then his blood test results came back. The number that really stood out? #atherosclerosis #cardiovasculardisease #hearthealth #hightriglycerides #hypertriglyceridemia #lowertriglycerides #triglycerides
Claudia Gonzaga-Jauregui 🧬Work from my previous life in industry looking at response to treatment in the context of LPL pathway variants in severe #hypertriglyceridemia patients finally published today @Nature Medicine.
The future of clinical trials will be to correlate genomic information with drug response & effects
https://www.nature.com/articles/s41591-023-02222-w
The future of clinical trials will be to correlate genomic information with drug response & effects
https://www.nature.com/articles/s41591-023-02222-w
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial - Nature Medicine
The potential of evinacumab, a monoclonal antibody targeting angiopoietin-like 3, for reducing triglyceride levels was tested in patients with severe hypertriglyceridemia due to differing genetic etiologies.